You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
諾唯贊(688105.SH):預計一季度淨利潤450萬元至550萬元 同比扭虧為盈
格隆匯 04-17 15:58

格隆匯4月17日丨諾唯贊(688105.SH)公佈,2024年第一季度實現營業收入30,000萬元至31,500萬元,與上年同期(法定披露數據)相比,將增加-219萬元至1,281萬元,同比增加-0.7%至4%。2024年第一季度實現歸屬於母公司所有者的淨利潤450萬元至550萬元,與上年同期(法定披露數據)相比,將增加5,512萬元至5,612萬元,同比增加109%至111%,實現扭虧為盈。2024年第一季度實現歸屬於母公司所有者扣除非經常性損益後的淨利潤-1,670萬元至-1,570萬元,與上年同期(法定披露數據)相比,將增加5,842萬元至5,942萬元,虧損幅度大幅收窄。

經過2023年度的佈局,公司生命科學業務提取、細胞、蛋白等新產品線,產品矩陣進一步完善,憑藉已有的成熟銷售體系,客單價與市場覆蓋率快速提升,報吿期內相關銷售收入增長顯著。公司國際業務隨着業務流程不斷優化,營銷網絡與供應鏈建設的逐步完善,有效客户拜訪量與全球化交付能力得到有效提升,國際業務銷售收入同比增長顯著。此外,基於公司體外診斷業務呼吸道病原體檢測項目的商業化、生物醫藥業務新藥研發試劑市場佔有率的進一步提升以及抗體發現與商業化項目里程碑款到賬等因素,報吿期內公司常規業務收入規模進一步增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account